Results 21 to 30 of about 6,404 (193)

Zoster Vaccine Recombinant, Adjuvanted [PDF]

Hospital Pharmacy, 2018
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Kalvin, Stoker, Terri L, Levien, Danial E, Baker   +2 more
openaire   +2 more sources

Safety and Immunogenicity of Adjuvanted Recombinant Subunit Herpes Zoster Vaccine in Lung Transplant Recipients. [PDF]

, 2021
Lung transplant recipients are at high risk for herpes zoster and preventive measures are a significant unmet need. We investigated the safety and immunogenicity of two doses of a recombinant zoster vaccine (RZV) in lung transplant recipients (≥50 years).
L'Huillier, Arnaud G., Kumar, Deepali, Ferreira, Victor H., Marinelli, Tina, Miao, Congrong, L'Huillier, Arnaud G, Ku, Terrance, Ferreira, Victor H, Schmid, D Scott, Juvet, Stephen, Hirzel, Cedric, Ierullo, Matthew, Humar, Atul, Schmid, D. Scott   +13 more
core   +1 more source

Immunogenicity in Mice Immunized with Recombinant Adenoviruses Expressing Varicella-Zoster Virus Envelope Glycoprotein E

Viruses, 2023
Herpes zoster (HZ) is a disease caused by the reactivation of latent varicella-zoster virus (VZV). The subunit vaccine, Shingrix®, and live attenuated vaccine, Zostavax®, could be used as an HZ vaccine that prevents HZ from being developed due to the ...
Yanpeng Zheng, Lei Huang, Huiru Ding, Huawei Xu, Rigan Shu, Jiemei Yu, Xianglei Peng, Yuanhui Fu, Jinsheng He   +8 more
doaj   +1 more source

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.

, 2019
Herpes zoster, a frequent complication following autologous hematopoietic stem cell transplantation (HSCT), is associated with significant morbidity. A nonlive adjuvanted recombinant zoster vaccine has been developed to prevent posttransplantation zoster.
Lopez-Fauqued, Marta, de la Serna, Javier, Rocci, Alberto, López-Jiménez, Javier, Vural, Filiz, Johnston, Anna M, Campins, Magda, Gaidano, Gianluca, Satlin, Michael J, Boeckh, Michael J, ZOE-HSCT Study Group Collaborators, Schwartz, Stefan, Stadtmauer, Edward A, Vallejo Llamas, Carlos, El Idrissi, Mohamed, Bastidas, Adriana, Oostvogels, Lidia, Heineman, Thomas C, Grigg, Andrew, Lee, Je-Jung, Sullivan, Keith M, Solano, Carlos, Perez de Oteyza, Jaime, Lee, Dong-Gun, Issa, Nicolas C, Tan, Sen Mui, Campora, Laura, Pohlreich, David, Zuckerman, Tsila, Quittet, Philippe, Abhyankar, Sunil   +30 more
core   +3 more sources

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals [PDF]

Journal of the American Geriatrics Society, 2020
BACKGROUND/OBJECTIVES Frail participants are often under‐represented in randomized trials, raising questions about outcomes of interventions in real‐world settings. Frailty is strongly associated with vulnerability to illness and adverse health outcomes.
Desmond Curran, Joon H. Kim, Sean Matthews, Christophe Dessart, Myron J. Levin, Lidia Oostvogels, Megan E. Riley, Kenneth E. Schmader, Anthony L. Cunningham, Shelly A. McNeil, Anne E. Schuind, Melissa K. Andrew   +11 more
openaire   +2 more sources

Position paper of the Italian College of Rheumatologists (CReI) on herpes zoster vaccination [PDF]

Beyond Rheumatology, 2022
Herpes Zoster (HZ) is a blistering, painful and disabling cutaneous rash that can occur in any type of patient at any age. It is caused by reactivation of the Varicella Zoster Virus (VZV).
D. Marotto, P. Sarzi-Puttini, V. Giorgi, M. Benucci, A. Migliore, P. Amato, A. Riva   +6 more
doaj   +1 more source

Comparison of Vaccine Adverse Events Between Zoster Vaccine Live and Recombinant Zoster Vaccine: A Prospective Multicenter Survey. [PDF]

J Korean Med Sci
Yoon JG, Nham E, Choi YJ, Choi WS, Choi MJ, Seo YB, Lee J, Hyun H, Heo JY, Noh JY, Song JY, Cheong HJ.   +11 more
europepmc   +2 more sources

Vaccination in Kidney Transplant Candidates

Transplantation Direct, 2023
Background:. Kidney transplant (KT) candidates have historically low immunization rates against recommended vaccines. A retrospective single-center study of contemporary KT candidates was conducted to assess vaccination rates and vaccine uptake. Methods:.
Kiran Gajurel, MD, Tue Ngo, MD, MPH, Robert T. Fairman, PhD, MPH, Lewis H. McCurdy, MD   +3 more
doaj   +1 more source

A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine

American Journal of Epidemiology, 2022
Abstract The recombinant herpes zoster vaccine (RZV), approved as a 2-dose series in the United States in October 2017, has proven highly effective and generally safe. However, a small risk of Guillain-Barré syndrome after vaccination was identified after approval, and questions remain about other possible adverse events.
Yih, W Katherine, Kulldorff, Martin, Dashevsky, Inna, Maro, Judith C   +3 more
openaire   +2 more sources

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster

Human Vaccines & Immunotherapeutics, 2023
Herpes zoster (HZ) results from waning immunity following childhood infection with varicella zoster virus (VZV) but is preventable by vaccination with recombinant HZ vaccine or live HZ vaccine (two doses or one dose, respectively).
Marta Ulaszewska, Sarah Merelie, Sarah Sebastian, Teresa Lambe   +3 more
doaj   +1 more source